@FiercePharma: Germany bans dozens of drugs made by Dr. Reddy's, Unichem, others because of issues at GVK Bio. Story | Follow @FiercePharma
@CarlyHFierce: New financing helps Anergis take allergy vaccine to Phase III. More | Follow @CarlyHFierce
> Gore got a CE mark for its Viabahn endoprosthesis to improve blood flow in symptomatic obstruction of peripheral veins, excluding the venae cavae and pulmonary veins. Release
> Baxter ($BAX) filed an SEC form confirming a mid-2015 spinoff of its biopharmaceutical business. Release
> CVRx received CE mark to expand labeling of the Barostim neo System as safe for use MRI scans, benefiting patients receiving Barostim Therapy for heart failure or resistant hypertension. Release
> Vitastiq developed a sensor that works in conjunction with a smartphone app to measure a person's vitamin content by passing a sensor over their skin. Story
> The NIH Pain Consortium dsicussed research standards for chronic low-back pain to address the challenge of comparing data across different studies. Release
Medical Device News
@FierceMedDev: Startup gains FDA clearance for breast surgery guidance system. Story | Follow @FierceMedDev
@EmilyWFierce: C.R. Bard battling bid from plaintiffs to consolidate pelvic mesh suits. More | Follow @EmilyWFierce
> St. Jude gains CE mark for first pacemaker with MultiPoint Pacing. Article
> Omron partnership to give AliveCor more retail punch. News
Biotech News
@FierceBiotech: Amicus eyes a 2015 EU filing for its rare disease drug with FDA in sight. Article | Follow @FierceBiotech
@DamianFierce: The @nytimes digs into the medicinal ketamine issue, with cameos from Naurex, Cerecor and $JNJ. More | Follow @DamianFierce
> Naurex posts the positive PhIIb data that helped it reel in $80M. Story
> Merck hits a hiccup with its new Ebola vaccine. News
> Bellicum battles for CAR-T spotlight with a $121M IPO pitch. Article
Vaccines News
> Amgen tests T-Vec's combo potential in trial with Merck's Keytruda. More
> Merck Vaccines president Gerberding leaving post for EVP role. Item
> Ebola vaccine makers Merck, GSK, J&J get legal protections in U.S. thanks to HHS declaration. Report
> Merck wins FDA approval for Gardasil follow-up. Story
> PaxVax meets primary endpoints in PhIII cholera vaccine trial. Article
Pharma Manufacturing News
> AstraZeneca closing U.S. plant, costing 180 jobs. Story
> More Novartis jobs cut in New York as plant suffers drawn-out drawdown. Report
> Romark building $110M plant in Puerto Rico. More
> Indonesia's Indofarma and Kimia combine manufacturing, supply chain strengths. News
> Indian drugmakers lambast proposed PET packaging ban. Article